Evercore Wealth Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Evercore Wealth Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,147	Closed	-$377K	–	439
2021 Q2	$377K	Sell	11,147 -2,024	-15%	-$51.6K	0.01%	330
2021 Q1	$308K	Hold	13,171	–	–	0.01%	360
2020 Q4	$379K	Hold	13,171	–	–	0.01%	324
2020 Q3	$267K	Hold	13,171	–	–	0.01%	324
2020 Q2	$396K	Hold	13,171	–	–	0.01%	283
2020 Q1	$414K	Buy	+13,171	New	+$458K	0.01%	259

Evercore Wealth Management's CNST Position: Q3 2021 in Review

Evercore Wealth Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 11,147 shares — an estimated $377K sold.

Evercore Wealth Management first reported a position in CNST in Q1 2020 and held it in 6 quarters. The position peaked at $414K in Q1 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Evercore Wealth Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Evercore Wealth Management sold 11,147 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $377K.
Evercore Wealth Management first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 6 quarters.
Evercore Wealth Management's Constellation Pharmaceuticals, Inc. position peaked at $414K in Q1 2020.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Evercore Wealth Management's 13F filing for Q3 2021, filed 15 Nov 2021.